logo
logo
7-DAY TRIAL

Discover funding patterns that signal buying intent

Identify companies whose recent funding indicates they're ready to invest in solutions like yours.

Real-time monitoring • AI-powered intent scoring • Direct executive contacts
Trial includes:
Complete platform access
Buyer intent analysis for your offering
Real-time Chrome & Slack alerts
No credit card required • Cancel anytime

Noveome Biotherapeutics announced it raised $36.2 Million in an amended filing from an offering of $51.3 Million

Aug 08, 202411 months ago

Amount Raised

$36.2 Million

PittsburghBiotechnology

Company Information

Company

Noveome Biotherapeutics

Location

100 TECHNOLOGY DRIVE

Pittsburgh, Pennsylvania, United States

About

Noveome Biotherapeutics, Inc. is a clinical stage company focused on breakthrough therapies for the regenerative repair of inflamed or damaged tissues. The company, originally founded as Stemnion, Inc., is located in the heart of Pittsburgh near the Southside Works. Noveome is passionate about growing its business in Allegheny County and helping the region to become a world leader in biotherapeutic research and development. Noveome Biotherapeutics, Inc. is a dynamic biopharmaceutical company with an innovative platform technology that represents a paradigm shift in drug development. Unlike most drugs that are single molecules directed at specific indications, Noveome’s product is a complex mixture of biomolecules that is believed to have the ability to treat a wide range of conditions and injuries. Noveome collaborates with major research centers to advance these therapeutic applications.

FundzWatch™ Score

85
Medium Activity

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People

Sign in to view contact details

Sign in to view contact details